As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Most recently, he served as Chief Operating Officer of Prometheus Biosciences, a biotechnology company focused on gastrointestinal diseases that was acquired by Merck for $10.8 billion ... leadership ...
In 2024, we established a license and research collaboration with MSD (tradename of Merck & Co., Inc., Rahway ... We are supported by leading life science investors SV Health Investors, Johnson & ...
DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
Through its Life Science Solutions segment, the firm operates in the genomics market. The company has a strong geographic ...
Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...
© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback